Trial Profile
Study on antiangiogenic transformation medicine of advanced colorectal cancer based on APE1 expression
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2018
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 13 Feb 2018 New trial record